Je was op zoek naar: raltegravirgruppen (Deens - Engels)

ved de kliniske undersøgelser med behandlingserfarne hiv- inficerede patienter, blev en mindre øgning i forekomsten af cancer observeret i raltegravirgruppen i sammenligning med gruppen, der kun fik optimeret baggrundsterapi.
during the clinical studies in treatment-experienced hiv-infected patients there was a slightly higher rate of cancer in the raltegravir group compared to the group that received only optimised background therapy.

i begge studier i uge 24 blev hæmning af hiv-rna til under 50 kopier/ml opretholdt hos 84,4% af raltegravirgruppen versus 90,6% af lopinavir (+) ritonavir-gruppen (non-completers = failure).
in both studies at week 24, suppression of hiv rna to less than 50 copies/ml was maintained in 84.4 % of the raltegravir group versus 90.6 % of the lopinavir (+) ritonavir group, (non-completers = failure).